A Phase II Trial with the Combination of Plinabulin (Plin) Pegfilgrastim (Peg): Evaluation of the Reversal of Peg's Immune-Suppressive Potential by the Addition of Plinto Peg
Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+ Cells through a Mechanism of Action Different from G-CSF and from CXCR4 Inhibition
Pegfilgrastim, but not Plinabulin, Generates a Blood Myeloid Cell (BMC) Repertoire with a Predominant Immunosuppressive Phenotype
Plinabulin (Plin), a Novel Non-G-CSF Molecule for the Prevention of Chemotherapy-Induced Neutropenia (CIN), Has the Potential to Positively Impact Tumor Micro Environment
Plinabulin-Associated Neutrophil Demargination: Evidence for a Clinically Relevant Mechanism of Action for the Prevention of Chemotherapy-Induced-Neutropenia
© BeyondSpring Inc. All Rights Reserved.